A Novel Approach for Sericin-Conjugated Silver Nanoparticle Synthesis and Their Potential as Microbicide Candidates |
Lv, Xiaowen
(Department of Pediatrics, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine)
Wang, Huanru (Center for Public Health Research, Medical School, Nanjing University) Su, Airong (Central Laboratory, The Second Affiliated Hospital of Nanjing Medical University) Chu, Ying (Central Laboratory, The Affiliated Wujin People's Hospital of Jiangsu University) |
1 | Hirsch LR, Stafford R, Bankson J, Sershen S, Rivera B, Price R, et al. 2003. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc. Natl. Acad. Sci. USA 100: 13549-13554. DOI |
2 | Liau S, Read D, Pugh W, Furr J, Russell A. 1997. Interaction of silver nitrate with readily identifiable groups: relationship to the antibacterial action of silver ions. Lett. Appl. Microbiol. 25: 279-283. DOI |
3 | Nomiya K, Yoshizawa A, Tsukagoshi K, Kasuga NC, Hirakawa S, Watanabe J. 2004. Synthesis and structural characterization of silver(I), aluminium(III) and cobalt(II) complexes with 4-isopropyltropolone (hinokitiol) showing noteworthy biological activities. Action of silver(I)-oxygen bonding complexes on the antimicrobial activities. J. Inorg. Biochem. 98: 46-60. DOI |
4 | Gupta A, Silver S. 1998. Molecular genetics: silver as a biocide: will resistance become a problem? Nat. Biotechnol. 16: 888. DOI |
5 | Fedlheim DL, Foss CA. 2001. Metal Nanoparticles: Synthesis, Characterization, and Applications. CRC Press, Boca Raton, FL. |
6 | Lok C-N, Ho C-M, Chen R, He Q-Y, Yu W-Y, Sun H, et al. 2006. Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J. Proteome Res. 5: 916-924. DOI |
7 | Das R, Gang S, Nath SS. 2011. Preparation and antibacterial activity of silver nanoparticles. J. Biomater. Nanobiotechnol. 2: 472-475. DOI |
8 | Balzarini J, Van Damme L. 2007. Microbicide drug candidates to prevent HIV infection. Lancet 369: 787-797. DOI |
9 | Galdiero S, Falanga A, Vitiello M, Cantisani M, Marra V, Galdiero M. 2011. Silver nanoparticles as potential antiviral agents. Molecules 16: 8894-8918. DOI |
10 | Alanis AJ. 2005. Resistance to antibiotics: are we in the postantibiotic era? Arch. Med. Res. 36: 697-705. DOI |
11 | Fauci AS. 1999. The AIDS epidemic - considerations for the 21st century. N. Engl. J. Med. 341: 1046-1050. DOI |
12 | Kahn JO, Walker BD. 1998. Acute human immunodeficiency virus type 1 infection. N. Engl. J. Med. 339: 33-39. DOI |
13 | Stone A. 2002. Microbicides: a new approach to preventing HIV and other sexually transmitted infections. Nat. Rev. Drug Discov. 1: 977-985. DOI |
14 | AshaRani P, Low Kah Mun G, Hande MP, Valiyaveettil S. 2008. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3: 279-290. |
15 | Li C, Wang X, Chen F, Zhang C, Zhi X, Wang K, et al. 2013. The antifungal activity of graphene oxide-silver nanocomposites. Biomaterials 34: 3882-3890. DOI |
16 | Elechiguerra JL, Burt JL, Morones JR, Camacho-Bragado A, Gao X, Lara HH, et al. 2005. Interaction of silver nanoparticles with HIV-1. J. Nanobiotechnol. 3: 1-10. DOI |
17 | Baram-Pinto D, Shukla S, Perkas N, Gedanken A, Sarid R. 2009. Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate. Bioconjug. Chem. 20: 1497-1502. DOI |
18 | Zhang YQ. 2002. Applications of natural silk protein sericin in biomaterials. Biotechnol. Adv. 20: 91-100. DOI |
19 | Johnson V, Byington R, Aldovani A, Walker B. 1990. Infectivity assay (virus yield assay), pp. 71-76. In Aldovani A and Walker BD (eds.), Techniques in HIV research. Stockton Press, New York, NY. |
20 | Li M, Gao F, Mascola JR, Stamatatos L, Polonis VR, Koutsoukos M, et al. 2005. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J. Virol. 79: 10108-10125. DOI |
21 | Pan H, Zhang Y, He G-X, Katagori N, Chen H. 2014. A comparison of conventional methods for the quantification of bacterial cells after exposure to metal oxide nanoparticles. BMC Microbiol. 14: 222. DOI |
22 | Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramirez JT, et al. 2005. The bactericidal effect of silver nanoparticles. Nanotechnology 16: 2346-2353. DOI |
23 | Ravichandran R. 2009. Nanotechnology-based drug delivery systems. Nanobiotechnology 5: 17-33. DOI |
24 | Bonnemann H, Richards RM. 2001. Nanoscopic metal particles − synthetic methods and potential applications. Eur. J. Inorg. Chem. 2001: 2455-2480. DOI |
25 | Neu HC. 1992. The crisis in antibiotic resistance. Science 257: 1064-1073. DOI |